Here's my thoughts on reading between the lines on Rory's

New Post Public Reply Private Reply Replies (4) Message Board
redspeed redspeed #5454
420
Here's my thoughts on reading between the lines on Rory's letter below.

But before I do:

I've said this plenty of times. Everyone should do their own DD and not go by anything anyone posts here including myself. Do you own DD. Make your own decisions and live with those decisions rather then blaming others for your own investment decisions or feeling the need to vent on this board. If you have "concerns" go do some DD yourself and share instead of whining. You many notice that 100% of those that whine have never shared any DD. It's a sign they maybe should be invested in Savings Bonds and not OTC companies

These are my thoughts when trying to read between the lines.

"As I mentioned briefly on last week’s CEOMoney show, the next 90 -100 days will be transformational in a very positive way for the company"

Actual uplisting or plans of uplisting in the next 3 months.

"we are not a typical OTC company and soon everyone will understand what I meant."

This is because FUSZ will be a nasdaq or nyse company this year

"I cannot do a SHAC and release info in a piecemeal fashion"

This has to be the first advice Donohoe Advisory gave nFUSZ. Stop spoon feeding information as it only works in favor of flippers and shorts. Longs already have done their DD and know what's coming. Let the others that have done no DD and just get it from other longs posting it on the board to be in the dark.

"It needs to all be disclosed in a big public way when ready"

Piecemealing info takes the market surprise out of it and ends up coming across as "oh, we already knew that and it was built into the sp". Let the market be surprised/

"allow the professionals to do their job and allow them to take the lead"

Donohoe Advisory are experts on M&A and Uplisting. Let them lead and get the company to that "transformed" state over the next 3 months

"I know that must sound cryptic, but we need to follow the rules to the letter "

Not cryptic at all. If you are doing any M&A or uplisting the rules are strict and have to be followed so you don't have any hiccups and delays

Get Listed
Donohoe Advisory will help your company obtain a listing on a national securities exchange.

We specialize in assisting companies with the preparation and submission of listing applications and related documentation. We will serve as the primary point of contact with the exchange. We can identify, address and resolve problems proactively before they become insurmountable obstacles. Further, given our familiarity with the listing rules and procedures and exchange decision-makers, we can expedite the application and listing process, enabling our clients to get listed faster and at less cost.

Expert Advice
Stock exchanges have complex rules and policies relating to financing and acquisition transactions and the maintenance of an appropriate corporate governance structure. We can help companies structure transactions appropriately and creatively so as to satisfy the rules and policies and obtain exchange approval.

June 22, 2018 - Congratulations to OptimizeRx (OPRX) on its new listing on The Nasdaq Capital Market.
by Carla Maria Graves on in Announcements

June 20, 2018 - Congratulations to Naked Brand Group Limited on the merger and new listing on The Nasdaq Capital Market

May 4, 2018 - Congratulations to Xspand Products Lab, Inc. (XSPL) on its Nasdaq listing

http://www.donohoeadvisory.com/


pearflix S1E0 by pearsby09

Hi
Thanks for reaching out. There is a lot happening right now that I am simply unable to share just yet. All of it is positive, very positive, and all of it is intended to enhance shareholder value in a meaningful way. As I mentioned briefly on last week’s CEOMoney show, the next 90 -100 days will be transformational in a very positive way for the company. We are executing the Master Plan with a team of professionals, all of whom will be identified shortly. Be patient. It will be well worth it. As I’ve stated repeatedly, we are not a typical OTC company and soon everyone will understand what I meant.
Best,
Rory

pearflix S1E1 by pearsby09

I’m fine with it being shared privately to the longs so as not to create a new target for the parasites to throw darts at. There will be a formal news release to disclose all that has been in the works but for reasons I am unable to provide right now, I cannot do a SHAC and release info in a piecemeal fashion. It needs to all be disclosed in a big public way when ready. I will say that we’re working with a team of superstars and I couldn’t be more thrilled. I think you know that I prefer to share as much information as I am able as and when it is happening, but this is a situation where I have to allow the professionals to do their job and allow them to take the lead. I know that must sound cryptic, but we need to follow the rules to the letter

TON Strategy Co. (TONX) Stock Research Links

TONX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading

Top 5 Most Recently Viewed Articles

SBVA Triumphs as Venture Capital Leader in Prestigious Award

Updated Category News Views 194

SBVA Achieves Prestigious Recognition SBVA, formerly known as SoftBank Ventures Asia, recently earned the esteemed title of "VC of the Year" at the annual Korea Venture Capital Awards. This significant honor highlights SBVA's remarkable investment performances and its vital role in enhancing the venture ecosystem. The Importance of the Korea Venture Capital Awards The...

Continue Reading
Strategic Acquisition: TopBuild Expands with Metro Supply Company

Updated Category News Views 116

Strategic Acquisition by TopBuild TopBuild Corp. (NYSE:BLD), a leader in insulation installation and specialty distribution for the construction sector, has recently made a significant move by agreeing to acquire Metro Supply Company. This acquisition is set to enhance TopBuild’s offerings in the commercial and industrial insulation market and is expected to bring in...

Continue Reading
Key Class Action Update on MoonLake Immunotherapeutics (MLTX)

Updated Category News Views 117

MoonLake Immunotherapeutics Faces Class Action Lawsuit Investors should be aware that MoonLake Immunotherapeutics (NASDAQ: MLTX) is currently facing a class action lawsuit due to alleged violations of securities laws. The DJS Law Group is actively reminding shareholders of their rights in light of this legal action, emphasizing the importance of staying informed during...

Continue Reading
Columbus McKinnon Set to Shine at Global Industrial Conference

Updated Category News Views 119

Columbus McKinnon Corporation's Participation in a Key Event Columbus McKinnon Corporation (Nasdaq: CMCO), a prominent name in the design and manufacturing of motion solutions, is excited to announce its participation in an upcoming event that is significant for the industry. The company will showcase its expertise at the Baird Global Industrial Conference. This important...

Continue Reading
The Growth of a $100 Investment in Norfolk Southern Over 20 Years

Updated Category News Views 64

The Benefits of Long-Term Investments in Norfolk Southern Investing wisely can truly change your financial landscape, and Norfolk Southern (NYSE: NSC) is a stellar example of this. Over the last 20 years, investing in NSC has yielded remarkable results, achieving an annualized growth rate of 5.31%. This outstanding performance has led to an impressive average annual...

Continue Reading